American Bio Medica (Kinderhook, New York) said that it received a notice from the Nasdaq on Nov. 12 informing it that for the last 30 consecutive business days, the bid price of the company's common stock has closed below the minimum $1 per share requirement for continued inclusion under Marketplace Rule 4310(c)(4).

The letter stated that under Marketplace Rule 4310(c)(8)(D), the company will be provided with 180 calendar days, or until May 12, 2008, to regain compliance with Marketplace Rule 4310(c)(4). To regain compliance, anytime before May 12, 2008, the bid price of the Company's common stock must close at $1 per share or more for a minimum of 10 consecutive business days.

American Bio Medica makes immunoassay diagnostic test kits.

No Comments